Biomarin Pharmaceutical Inc (BMRN) — Cash Flow Quality Index
Biomarin Pharmaceutical Inc (BMRN) has a Cash Flow Quality Index of 0.72x as of December 2025. Operating cash flow of $99.64 Million is below net income of $139.11 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how much of Biomarin Pharmaceutical Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Biomarin Pharmaceutical Inc Cash Flow Quality Index (2008–2025)
Historical Cash Flow Quality Index for Biomarin Pharmaceutical Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BMRN intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Biomarin Pharmaceutical Inc (2008–2025)
Year-by-year earnings quality comparison for Biomarin Pharmaceutical Inc. For live market cap and the full company financial profile, see BMRN market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.37x | $827.99 Million | $348.90 Million | ▲ +76.8% |
| 2024 | 1.34x | $572.84 Million | $426.86 Million | ▲ +41.3% |
| 2023 | 0.95x | $159.26 Million | $167.65 Million | ▼ -23.5% |
| 2022 | 1.24x | $175.90 Million | $141.56 Million | ▲ +1150.5% |
| 2020 | 0.10x | $85.36 Million | $859.10 Million | ▲ +9.1% |
| 2010 | 0.09x | $18.75 Million | $205.82 Million | ▲ +130.6% |
| 2008 | -0.30x | $-9.18 Million | $30.83 Million | — |